Article discussing the impact of ivermectin on onchocerciasis, particularly through Merck & Co., Inc., Kenilworth, N.J., U.S.A.’s * establishment of the Mectizan® Distribution Program (MDP), which was founded to provide a complementary approach to controlling the disabling consequences of this parasitic infection. Tielsch et al, Tropical Medicine and International Health, Volume 9 No 4 pp A45-A56 Suppl, April 2004.
*Merck & Co., Inc., Kenilworth, N.J., U.S.A., is known as MSD outside of the United States and Canada.